Company Insights – Page 2 – media

Packaging Error Prompts Allergan to Recall Sample Packs of Taytulla Contraceptive Pills

A voluntary nationwide recall of 168,768 physician sample packs of Taytulla capsules was issued by the Dublin-based drug maker. The action came in the wake of a discovery by a physician of a package in which four non-hormonal placebo capsules replaced active capsules in the first four days of therapy.
- Source: Ddu
- 881
- May 30, 2018
Company Insights contraceptive drugs
Blink Health to take legal actions against MedImpact Healthcare System

mHealth Application developer company Blink Health, brought legal charges against MedImpact Healthcare system, claiming the company to be a peddler of opioids.
- Source: Ddu
- 604
- May 29, 2018
Company Insights mHealth opioid
Healthcare Sector Has Not Fully Exploited Data Analytics Potential

India-based Omega Healthcare has categorically stated that the growth of data analytics and cloud intelligence firms in the Indian healthcare sector has little scope. The company plans to hire around 1,200 - 1,500 people for exploring emerging markets like the United Arab Emirates.
- Source: Ddu
- 744
- May 28, 2018
Company Insights digital health India
Sesen Bio Presents Bladder Cancer Treatment Data Following Name Change

The annual meeting of the American Urological Association had Sesen Bio present its three-month data for its bladder cancer treatment Vicinium. This was Sesen Bio’s first readout following its name change from Eleven Biotherapeutics.
- Source: Ddu
- 636
- May 22, 2018
bladder cancer cancer Company Insights
Security issues with Philips, GE, and Silex medical devices

Serious security flaws were discovered in Philips, GE and Silex medical devices that, if exploited, could allow authorized access and let a hacker obtain elevated privileges, according to two separate U.S. Department of Homeland Security ICS-CERT alerts issued this month.
- Source: HealthIT news
- 639
- May 15, 2018
Company Insights cybersecurity medical device
Integration of next-generation sequencing data in clinical trials facilitated by DNAnexus

A clinical trial solution has been unveiled by DNAnexus that facilitates the integration of genomics data sourced from next-generation sequencing (NGS) into clinical studies. A cloud-based genomic data collection platform is offered by DNAnexus.
- Source: Ddu
- 552
- May 15, 2018
Company Insights digital health
Qventus raised $30M investment from Bessemer Venture Partners

Mountain View, California startup - Qventus a healthcare management tech platform which uses artificial intelligence to improve hospital workflow, closed at $30 million in series B funding which will be used to expand its platform. The funding was led by Bessemer Venture Partners along with few other participants. Including this latest funding, Qventus bagged total $43 million.
- Source: Ddu
- 540
- May 15, 2018
AI Company Insights digital health
Biotechnology Company Abpro postpones $69M IPO

According to reports, the biotechnology company Abpro has rescheduled its $96 million IPO, delaying a capital infusion it hoped would support the first clinical trials of its lead product candidates over the next year.
- Source: Ddu
- 612
- May 14, 2018
biotech Company Insights IPO
Amazon focusing to upend healthcare sector with Alexa

The team is focusing to make Alex, the voice assistant, more convenient and useful in the health-care sector, which requires regulations and data privacy set by the HIPAA – Health Insurance Portability and Accountability Act. The experts are aiming to work on diabetes management, assistance for mother, infants and the elderly.
- Source: Ddu
- 714
- May 11, 2018
Company Insights digital health mHealth
Safer HIV drugs taken off the shelf by Gilead

It has been stated by the patients that Gilead concealed crucial information that the TDF drugs could trigger kidney and bone risks. A safer alternative in the form of TAF could have been incorporated while marketing Truvada and Atripla. The research into TAF was deliberately stopped and the drugs are not likely to be brought to the shelf in the near future.
- Source: drugdu
- 868
- May 11, 2018
Company Insights Gilead HIV

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.